This site is intended for customers outside the United States. | Switch to: United States
Return Home
Indications and Important Safety Information
Visit Abbott Medical Optics
nav_patient nav_physician

Design


Text Size: SM / MD / LG

IT'S THE ONE WITH THE NEXT-GENERATION DESIGN

ProTEC 360° edge design increases protection

360 degree square edge for uninterrupted contact at the haptic-optic junctionFrosted edge designed to minimize unwanted edge glare
360° square edge for uninterrupted contact at the haptic-optic junctionFrosted edge designed to minimize unwanted edge glare
Other IOLTECNIS® 1-Piece IOL
Other IOLTECNIS 1-Piece IOL
Limits LEC migration at the haptic-optic junction(22)

Tri-Fix 3-Point Fixation designed to increase stability

Tri-Fix Design

Tri-Fix Design

  • Haptics offset allows three points of capsular bag fixation
  • Provides refractive predictability, long-term stability, and centration

TECNIS® 1-Piece IOL increases ease of implantation

  • Bag-friendly, coplanar delivery
  • Proprietary surface treatment for ease of unfolding
Haptic Loops Slim Lens Profile
Haptic LoopsSlim Lens Profile
Polished haptic loops enable controlled, gentle unfolding in capsular bagReduced center thickness for slim lens profile facilitates implantation

Watch an implantation demonstration

Indications and Important Safety Information

TECNIS® IOLs

Caution

Federal law restricts this device to sale by or on the order of a physician.

Indications

TECNIS® lenses are indicated for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by extracapsular cataract extraction. These devices are intended to be placed in the capsular bag.

Warnings

Physicians considering lens implantation under any of the conditions described in the Directions for Use labeling should weigh the potential risk/benefit ratio prior to implanting a lens.

Precautions

Do not resterilize or autoclave. Use only sterile irrigating solutions such as balanced salt solution or sterile normal saline. Do not store in direct sunlight or over 45°C.

Adverse Events

Adverse events occurred at rates between 1.6% and 3.3% during the clinical trials for TECNIS® IOLs or their “parent” IOLs. These events included macular edema, endophthalmitis, anterior lens tissue ongrowth, lens dislocation, hypopyon, corneal edema, iritis, hyphema, secondary glaucoma, and secondary surgical intervention. 

Attention

Reference the Directions for Use for a complete listing of indications, warnings, and precautions.

References

22. Nixon DR. New technologies for premium outcomes: Next generation phaco and TECNIS® 1-Piece IOL. Presented at ESCRS, 2007.

Back to Top of Page

LegalPrivacy PolicyTerms of Use
Video Visit Abbott Medical Optics Return Home